PPD's Government Contract for Public Health Emergencies
PPD has been selected by the HHS' Biomedical Advanced Research and Development Authority in its Medical Countermeasure Clinical Studies Network.
PPD has been selected by the HHS' Biomedical Advanced Research and Development Authority in its Medical Countermeasure Clinical Studies Network. That Network supports initiatives that help protect health against bioterrorism, pandemic influenza and other public health emergencies. PPD will plan, perform, monitor and interpret Phase I-IV clinical studies that are required by the U.S. Food and Drug Administration for the approval of a product for human use, comparing the properties of multiple products or evaluating the potency of products stored in U.S. government stockpiles.
Read the full release here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
